Abstract (EN):
Background and Objective: Evaluate the activity of dopamine-beta-hydroxylase (D beta H) as well as the effect of the D beta H inhibitor nepicastat upon enzyme activity and levels of dopamine (DA) and norepinephrine (NE) in the rat left ventricle, kidney, and adrenal glands. Methods: D beta H assay consisted of the enzymatic hydroxylation of tyramine into octopamine, and DA and NE tissues levels were quantified by HPLC-ED. Results: Nepicastat (30 mg/kg, p.o.) reduced D beta H activity by 93% and 80% in the adrenals at 4 h and 8 h postdrug administration, accompanied by significant reductions in NE and epinephrine tissue levels and an increase in DA levels and of DA/NE tissue ratios, with similar findings for NE, DA and of DA/NE tissue ratios in left ventricle and kidney. D beta H activity in the left ventricle and kidney showed a high degree of variability, which does not allow corroboration of the effects of nepicastat upon catecholamine tissue levels. Conclusion: The assay of D beta H activity in heart and kidney lacks the necessary robustness, but D beta H activity in the adrenals appears to be an appropriate marker. However, the effect size upon DA/NE tissue ratios (an indirect measure of D beta H activity) as induced by nepicastat was very similar in sympathetically innervated tissues, left ventricle and kidney, and the adrenal medulla.
Language:
English
Type (Professor's evaluation):
Scientific
No. of pages:
8